Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis

(2012) J. J. Prochaska et al.   BMJ-British Medical Journal

Weight gain in smokers after quitting cigarettes: meta-analysis

(2012) H.-J. Aubin et al.   BMJ-British Medical Journal

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

(2011) S. Singh et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers

(2010) Deborah Lycett et al.   ADDICTION

Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease

(2010) Nancy A. Rigotti et al.   CIRCULATION

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries

(2010) Komelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review

(2010) J. R. Hughes et al.   NICOTINE & TOBACCO RESEARCH

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

(2009) Kornelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial

(2008) DA Wood et al.   LANCET